Submitted by Anonymous (not verified) on 6 January 2026 - 9:48
Human medicines European public assessment report (EPAR): Vaxneuvance, pneumococcal polysaccharide conjugate vaccine (adsorbed), Date of authorisation: 13/12/2021, Revision: 8, Status: Authorised
Source: